Literature DB >> 8796159

Retinopathy in haemoglobin C trait.

M Hingorani1, C R Bentley, H Jackson, F Betancourt, R Arya, W A Aclimandos, A C Bird.   

Abstract

Retinopathy associated with sickle-C and sickle cell disease is well described. Sickle trait and haemoglobin C trait are generally considered benign conditions, with infrequent systemic manifestations. Rare cases of retinopathy in sickle trait, in the presence of contributory factors, exist and we recently reported three such patients. The occurrence of retinopathy in haemoglobin C trait is even less well documented. Haemoglobin C does not cause red blood cell sickling but is known to decrease erythrocyte plasticity and increase blood viscosity. We report three cases in which haemoglobin C trait was associated with significant peripheral vascular occlusion and seafan formation (confirmed by fluorescein angiography) similar to that seen in sickle retinopathy. Two patients had coexistent systemic disease (hypertension and diabetes mellitus). Vitreous haemorrhage was the presenting feature in two patients. It is evident that haemoglobin C trait may be associated with sight-threatening complications.

Entities:  

Mesh:

Year:  1996        PMID: 8796159     DOI: 10.1038/eye.1996.70

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  6 in total

1.  Sickle cell-hemoglobin C retinopathy: transient obstruction of retinal and choroidal circulations and transient drying out of retinal neovessels.

Authors:  Alessandro Mantovani; Innocente Figini
Journal:  Int Ophthalmol       Date:  2008-02-23       Impact factor: 2.031

2.  Sickle trait in African-American hemodialysis patients and higher erythropoiesis-stimulating agent dose.

Authors:  Vimal K Derebail; Eduardo K Lacson; Abhijit V Kshirsagar; Nigel S Key; Susan L Hogan; Raymond M Hakim; Ann Mooney; Chinu M Jani; Curtis Johnson; Yichun Hu; Ronald J Falk; J Michael Lazarus
Journal:  J Am Soc Nephrol       Date:  2014-01-23       Impact factor: 10.121

3.  Hemoglobin AC retinopathy managed with vitrectomy and adjunctive bevacizumab.

Authors:  R Pokroy; U R Desai
Journal:  Eye (Lond)       Date:  2011-08-05       Impact factor: 3.775

4.  Two cases of hematuria with hemoglobin C trait.

Authors:  John David Spencer; John T Sanders; Bettina H Ault
Journal:  Pediatr Nephrol       Date:  2009-08-11       Impact factor: 3.714

5.  Sickle cell trait, hemoglobin C trait, and invasive pneumococcal disease.

Authors:  Katherine A Poehling; Laney S Light; Melissa Rhodes; Beverly M Snively; Natasha B Halasa; Ed Mitchel; William Schaffner; Allen S Craig; Marie R Griffin
Journal:  Epidemiology       Date:  2010-05       Impact factor: 4.822

6.  Variant hemoglobin phenotypes may account for differential erythropoiesis-stimulating agent dosing in African-American hemodialysis patients.

Authors:  Vimal K Derebail; Patrick H Nachman; Nigel S Key; Heather Ansede; Ronald J Falk; Wayne D Rosamond; Abhijit V Kshirsagar
Journal:  Kidney Int       Date:  2011-08-17       Impact factor: 10.612

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.